PaySauce (PYS) Q2 2026 TU earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2026 TU earnings summary
19 Nov, 2025Executive summary
Achieved record Annualised Recurring Revenue (ARR) of $9.2m in 2Q26, up 6% year-over-year, despite a challenging economic environment and lower interest rates.
Launched pilot of new Australian payroll product, with commercial launch planned for February 2026.
Financial highlights
Recurring revenue for the quarter reached $2.3m, up 4% year-over-year and 2% sequentially.
Processing fee revenue was $1.8m, up 14% year-over-year and 4% sequentially.
Interest revenue from customer funds declined 23% year-over-year due to falling interest rates.
Active customers at quarter-end totaled 8,506, up 9% year-over-year and 1% sequentially.
Outlook and guidance
Commercial launch in Australia remains on track for February 2026, following a successful pilot phase.
Management expresses optimism for the next six months, anticipating further growth and expansion.
Latest events from PaySauce
- ARR up 17% to $8.7m, profitability and customer base expanded, supporting scalable growth.PYS
H1 202512 Jan 2026 - Revenue and profit rose, supporting global expansion and improved efficiency.PYS
H1 202619 Nov 2025 - Strong revenue and customer growth, improved profitability, and focus on Australian expansion.PYS
AGM 2025 Presentation28 Sep 2025 - Recurring revenue up 6% YoY, processing fees up 17%, and Australian launch nearing.PYS
Q1 2026 TU7 Sep 2025 - Recurring revenue up 19% YoY and customer base up 9%, driven by platform unification.PYS
Q2 2025 TU13 Jun 2025 - First net profit achieved, recurring revenue up 32%, and $10m ARR targeted for future growth.PYS
AGM 2024 Presentation13 Jun 2025 - ARR up 18% YoY to $8.2m, with strong growth in recurring revenue and customer base.PYS
Q1 2025 TU13 Jun 2025 - Processing fee revenue surged 13% YoY in Q4 FY25, driven by 11% customer growth.PYS
Q4 2025 TU6 Jun 2025 - Double-digit growth in revenue, customers, and profitability, with strong cash flow and R&D investment.PYS
H2 20255 Jun 2025